Matteo Arnaldi withdrew from his Roland Garros semifinal match on Friday after a viral illness left him unable to compete [1].
The withdrawal is a significant disruption to the tournament's closing stages, as it grants an automatic spot in the championship match without a contest. This marks a rare occurrence in professional tennis, specifically during the high-stakes environment of a Grand Slam semifinal.
Arnaldi suffered from a viral illness that caused fatigue and vomiting throughout the night [2]. The symptoms left the Italian player unable to perform at a professional level, forcing the decision to pull out of the event in Paris [3].
As a result of the withdrawal, Flavio Cobolli advances to the final via walkover [1]. Cobolli, who was seeded No. 10 in the tournament [4], will now face Alexander Zverev in the championship match. Zverev entered the tournament as the No. 2 seed [4].
This event is historically rare for the sport. It is only the fourth time in the Open Era that a Grand Slam semifinal has ended as a walkover [5].
Arnaldi's exit leaves the final as a matchup between the 10th seed and the second seed. The tournament officials confirmed the change in the schedule following the announcement of Arnaldi's health status on Friday [1].
“Matteo Arnaldi withdrew from his Roland Garros semifinal match on Friday after a viral illness left him unable to compete.”
The rarity of a semifinal walkover in the Open Era underscores the physical toll of Grand Slam tournaments and the unpredictable nature of athlete health. For Cobolli, the walkover provides a significant physical advantage and recovery window before facing a higher-seeded opponent in Zverev, potentially shifting the competitive dynamics of the final.
